Cambridge biotech Relay races past goals in $400M IPO

Cancer startup Relay Therapeutics raised $400 million in its IPO Thursday, doubling the plans it laid out last month.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.